Update on melanocortin interventions for cachexia: progress toward clinical application.
about
Pathophysiology of anorexia in the cancer cachexia syndromeGhrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?Animal models of anorexia and cachexia.Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review.Cancer cachexia: mechanisms and clinical implications.Neuropeptides in the pathophysiology and treatment of cachexia.The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexiaControl of food intake by MC4-R signaling in the lateral hypothalamus, nucleus accumbens shell and ventral tegmental area: interactions with ethanol.Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats.Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexiaHypothalamic activation is essential for endotoxemia-induced acute muscle wasting.Pathophysiology and treatment options for cardiac anorexia.A rat in the labyrinth of anorexia nervosa: contributions of the activity-based anorexia rodent model to the understanding of anorexia nervosa.Insulin ameliorating endotoxaemia-induced muscle wasting is associated with the alteration of hypothalamic neuropeptides and inflammation in rats.JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.
P2860
Q26775294-07C50D84-98B4-419A-8F5E-7A0F0C0DEEC0Q30426403-85F77F96-7A76-46DE-87B3-368CA29B92DAQ30434298-20AF6E30-D4A7-4740-853F-0F79E10D6A12Q33956866-73F7C765-D73C-4420-951B-15FEAB3A9728Q34631019-9557922F-12AC-42DF-8525-00D7EE896F06Q34712204-7C0DD35C-F80D-4D11-AB4D-A1C3128A58B8Q35223982-86664685-3DE5-458E-8444-E2DADC4D88FBQ36129311-1573238D-944B-44E4-9E27-DF2247B43D21Q36328267-C71431B1-8FAA-483D-9FB2-42669C8F7FFDQ36737744-07FE836A-5DA1-4C5D-92D5-6D69366F2070Q37475891-E1ACC343-9AB9-4314-897D-44FE7E120FAFQ37843775-0B2DDAC0-A4A2-4A32-BC75-04D482B01286Q38077136-00B76E9A-AFFF-4904-BF00-2523C65CE676Q41745913-5B39A76D-D1EA-42BC-8A22-6350F82F55BFQ48191939-E5E3436A-74DB-4FFF-9DBA-0FCA270935D1
P2860
Update on melanocortin interventions for cachexia: progress toward clinical application.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Update on melanocortin interventions for cachexia: progress toward clinical application.
@ast
Update on melanocortin interventions for cachexia: progress toward clinical application.
@en
type
label
Update on melanocortin interventions for cachexia: progress toward clinical application.
@ast
Update on melanocortin interventions for cachexia: progress toward clinical application.
@en
prefLabel
Update on melanocortin interventions for cachexia: progress toward clinical application.
@ast
Update on melanocortin interventions for cachexia: progress toward clinical application.
@en
P2860
P1433
P1476
Update on melanocortin interventions for cachexia: progress toward clinical application.
@en
P2860
P304
P356
10.1016/J.NUT.2009.07.003
P577
2009-12-08T00:00:00Z